ARO-ATXN2 Injection
AROATXN2-1001
Phase 1 small_molecule active
Quick answer
ARO-ATXN2 Injection for Spinocerebellar Ataxia Type 2 is a Phase 1 program (small_molecule) at Arrowhead Pharmaceuticals Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arrowhead Pharmaceuticals Ireland Limited
- Indication
- Spinocerebellar Ataxia Type 2
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active